Back to search
FDAFDA · Food and drugs·Recall number D-0513-2017

Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01.

Published March 15, 2017 · Recall initiated: February 23, 2017

Summary

FDA records drug Class II recall D-0513-2017, published March 15, 2017 and initiated February 23, 2017. Recalling firm: Mckesson Packaging Services; Status: Completed; Reported quantity: 6,717 cartons; Lot: Lot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance: foreign material found in the bulk inventory.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mckesson Packaging Services
Distributor
Nationwide in the USA
Lot
Lot numbers: 0113784, 0113786, 0113834, 0113887, Exp. 07/18
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aspirin Chewable Tablets, 81 mg, (NSAID*), packaged in UD 750 Tablets (25 x 30) tablets in blisters per carton, Dist. By: McKesson Packaging Services, a business unit of McKesson Corporation, 7101 Weddington Rd., Concord, NC 28027, NDC 63739-434-01. recalled?

Yes. FDA published recall D-0513-2017 on March 15, 2017. Reported hazard: Presence of Foreign Substance: foreign material found in the bulk inventory.

What should I do if I have this product?

Voluntary: Firm initiated · Letter